newsfilter
← Latest News
Business Wire·

Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity

FC

Founded by a team of experts in aging biology, machine learning and drug development and based on pioneering research for resetting cell health by Dr. Janine Sengstack of UCSF Junevity's RESET platform uses